Biotech Blueprint
Episodes
Inside NImmune’s Phase 3 Push in Ulcerative Colitis
10 Dec 2025
Contributed by Lukas
I sat down with NImmune CEO Josep Bassaganya-Riera to talk about omilancor, their gut-restricted oral IBD drug now in Phase 3 clinical trials. We cove...
FDA Tightens Vaccine Pathways, Medicare Slashes Drug Prices — This Week in Biotech #80
10 Dec 2025
Contributed by Lukas
Plus Duchenne’s landmark phase 3 win, a survival boost in glioblastoma, motion sickness momentum at Vanda, and ACIP’s newborn vaccine chaos (Nov 2...
CDC’s Autism Reversal Shocks Experts, mRNA Flu Shot Advances, Big Oncology Wins - This Week in Biotech #79
24 Nov 2025
Contributed by Lukas
Subscribe to Biotech Blueprint at biotechblueprint.com
FDA Opens New Pathway, Pfizer’s $10B GLP-1 Win, and Biotech’s Return to Offense — This Week in Biotech #78
14 Nov 2025
Contributed by Lukas
Subscribe to Biotech Blueprint for free at biotechblueprint.com. A week of rare regulatory momentum, strategic M&A, and meaningful clinical wins.
Inside Sensible Biotechnologies: Reinventing mRNA Manufacturing
13 Nov 2025
Contributed by Lukas
Subscribe to Biotech Blueprint at biotechblueprint.com In today's episode:How an Oxford-born, YC-backed startup is betting that cell-based product...
Trump Reshapes Obesity Drug Prices, Novo Tops Pfizer Again — This Week in Biotech #77
08 Nov 2025
Contributed by Lukas
Subscribe to Biotech Blueprint for free at biotechblueprint.com.Pfizer’s courtroom gamble to block Novo Nordisk’s $10B Metsera takeover failed, an...
Novo tops Pfizer’s obesity bid; FDA moves to speed biosimilar approvals; Moderna–Merck rumors build — This Week in Biotech #76
31 Oct 2025
Contributed by Lukas
Subscribe to Biotech Blueprint newsletter for free at biotechblueprint.com.
Drug launch prices soar; mRNA shots linked to longer cancer survival — This Week in Biotech #75
26 Oct 2025
Contributed by Lukas
Subscribe to Biotech Blueprint for FREE at biotechblueprint.com.
How mRNA Could Defeat Latent Viruses and Train Immunity Against Cancer
21 Oct 2025
Contributed by Lukas
Subscribe to Biotech Blueprint for free at biotechblueprint.com. About this episode: mRNA’s next chapter isn’t just flu and COVID. We break ...
Trump cuts IVF & Medicaid drug prices; Novo buys Omeros; Lilly's GLP-1 orforglipron shines — This Week in Biotech #74
19 Oct 2025
Contributed by Lukas
Subscribe at biotechblueprint.com.
Pharma Tariffs on Ice, FDA Limits Filings, Amgen’s PCSK9 Win — This Week in Biotech #72 Pharma Tariffs on Ice, FDA Limits Filings, Amgen’s PCSK9 Win — This Week in Biotech #72
03 Oct 2025
Contributed by Lukas
Read the full edition or subscribe to Biotech Blueprint herehttps://www.biotechblueprint.com/p/pharma-tariffs-on-ice-fda-limits?r=474vk1
ACIP votes, Roche-89bio deal, Regeneron’s FOP win — This Week in Biotech #70
19 Sep 2025
Contributed by Lukas
Subscribe to Biotech Blueprint newsletter for free at biotechblueprint.com/embed
The mRNA Revolution: Beyond COVID to Cancer, Flu and Herpes Vaccines
18 Sep 2025
Contributed by Lukas
Welcome to Biotech Blueprint. If you want to subscribe to a free weekly biotech/pharma newsletter, you can do so here: https://www.biotechblueprint.co...
Novo’s Layoffs, Novartis’ $1.4B Buy, Pancreatic Cancer Progress — This Week in Biotech #69
12 Sep 2025
Contributed by Lukas
Subscribe to Biotech Blueprint, your free biotech & pharma newsletter released every Friday at biotechblueprint.com
Ionis' Olezarsen Win, Novartis Licenses Arrowhead, CDC Vaccine Fight — This Week in Biotech #68
05 Sep 2025
Contributed by Lukas
Subscribe to Biotech Blueprint FREE weekly newsletter HERE.
Monarez Fired, Novo’s srRNA Deal, ImmunityBio Wows in GBM — This Week in Biotech #67
29 Aug 2025
Contributed by Lukas
Subscribe to Biotech Blueprint for free HERE or at biotechblueprint.com
Viking Falls on Obesity Pill, Rocket’s Gene Therapy Resumes, FDA Greenlights Papzimeos — This Week in Biotech #66
22 Aug 2025
Contributed by Lukas
Subscribe to the Biotech Blueprint weekly newsletter for free HERE. Thanks for your support.
Lilly Bets on AI, Prasad Returns, and Brinsupri Breaks Through - This Week in Biotech #65
15 Aug 2025
Contributed by Lukas
Get the latest biotech and pharma news for free straight in your inbox. Follow Biotech Blueprint HERE.
RFK Jr. Ends mRNA Funding, Sarepta Beats Q2, and Eli Lilly Falls — This Week in Biotech #64
08 Aug 2025
Contributed by Lukas
Subscribe to Biotech Blueprint for free for weekly newsletters right in your inbox. Thanks for your support!
FDA Shake Up, Sarepta Rebounds, and Trump Targets Drug Prices — This Week in #Biotech 63
01 Aug 2025
Contributed by Lukas
Subscribe to Biotech Blueprint for free HERE and visit Biotech Blueprint website for more.
Sarepta, Elevidys, and the Future of AAV Gene Therapy
29 Jul 2025
Contributed by Lukas
Subscribe to Biotech Blueprint HERE and to Biotech Capital Compass HERE.In this episode of the Biotech Blueprint podcast, I teamed up with the Biotech...
Sarepta’s Gene Therapy Crisis Deepens — This Week in Biotech #62
25 Jul 2025
Contributed by Lukas
Subscribe to Biotech Blueprint HERE.
Sarepta’s $400M Pivot, MiNK’s 500% Surge, and AML Breakthroughs — This Week in Biotech #61
18 Jul 2025
Contributed by Lukas
Subscribe to Biotech Blueprint for free HERE.In this episode: Layoffs, CRLs, and standout trial data from Sarepta, MiNK, SELLAS, DiaMedica, and more (...
CRISPR in 2025: Clinical Use, Regulatory Pressure, and Future Promise
18 Jul 2025
Contributed by Lukas
Welcome back to Biotech Blueprint!In this week’s special episode, I teamed up with the Biotech Capital Compass to examine where gene editing stands ...
KalVista’s FDA Win, Merck’s $10B Deal, and CRISPR Momentum — Biotech #60
14 Jul 2025
Contributed by Lukas
Subscribe to our free newsletter HERE.Thanks for listening!
Sparks Fly in Biotech — This Week in Biotech #59
03 Jul 2025
Contributed by Lukas
Subscribe to Biotech Blueprint HERE.While the U.S. gears up for Independence Day, biotech is having its own kind of fireworks. In This Week in Biotech...
FDA Drama & Psychedelic Setback — This Week in Biotech #58
27 Jun 2025
Contributed by Lukas
Subscribe for FREE HERE.FDA turmoil impacts key drug decisions, Compass’s phase 3 psilocybin data spooks investors, and Exelixis soars on cancer res...
HIV Breakthrough & Gene Editing Deals — This Week in Biotech #57
20 Jun 2025
Contributed by Lukas
Subscribe for free HERE. Gilead’s HIV breakthrough, Lilly’s $1.3B gene editing deal, and FDA reform efforts. Listen to the biggest news from biote...
Biotech Caught Between AI Momentum and Political Turbulence — This Week in Biotech #56
13 Jun 2025
Contributed by Lukas
Subscribe to Biotech Blueprint, FREE weekly newsletter HERE. This week, Biotech Blueprint breaks down the crosswinds shaping the industry:– Novo Nor...
Navigating Biotech Jobs in 2025: AI, Networking, and Career Strategy
11 Jun 2025
Contributed by Lukas
Subscribe to Biotech Blueprint 👉HERE.In this episode of the Biotech Blueprint Podcast, host Katerina Roznik sits down with Steve Swan, CEO of the S...
ASCO Breakthroughs, Gene Therapy Stumbles, and Omada's IPO debut — This Week in Biotech #55
09 Jun 2025
Contributed by Lukas
Subscribe to Biotech Blueprint here.In this week’s episode, I break down the biggest stories shaping the biotech and pharma landscape from May 30 to...
CRISPR Setbacks, Vaccine Policy Reversed, and an Oral Antibiotic Breakthrough — This Week in Biotech #54
02 Jun 2025
Contributed by Lukas
In this week’s recap, we spotlight three biotech stories that reveal where the sector is headed, both the promise and the pitfalls:Gene therapy tria...
Organoids, AI, and the FDA’s Move Away from Animal Models
29 May 2025
Contributed by Lukas
Is this the end of animal testing? | Biotech Blueprint PodcastFor nearly a century, animal testing has been a cornerstone of drug development. But tha...
Tighter Boosters, Novavax's Win, and Psychedelic Signals — This Week in Biotech #53
23 May 2025
Contributed by Lukas
In this week’s recap, we cover three biotech stories that signal big shifts in regulation:FDA tightens Covid booster rules: The FDA announced it wil...
Medicare Benchmarking, Novo's Transition, and Biohaven's Setback — This Week in Biotech #52
19 May 2025
Contributed by Lukas
In this week’s episode, we break down three major biotech stories from May 9–16, 2025:• The White House revives the “Most Favored Nation” dr...
CRISPR, Prasad, and the NIH budget bomb — This Week in Biotech #51
11 May 2025
Contributed by Lukas
This Week in Biotech #51 (May 2–10, 2025)CRISPR’s cholesterol breakthrough, the FDA’s new CBER chief rattles markets, NIH faces historic budget ...
From Wall Street to Wet Lab: Mapping the Future of Biotech
03 May 2025
Contributed by Lukas
Biotech Blueprint is a newsletter and a podcast where biotech professionals and industry insiders come together to unpack the trends, challenges, and ...